1331 - Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

W.E.E Eberhardt,J Vanderpuye-Orgle,M Reck,D Waterhouse,B Smiechowski,K Bognar,E Van Eijndhoven,C Makris,A Blackwood-Chirchir,N Hertel,B Korytowsky,S Cope,J.R Penrod,A Shrestha

doi:10.1016/s0959-8049(17)30525-7

1331 - Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

W.E.E Eberhardt, J Vanderpuye-Orgle + Show 12 more

https://doi.org/10.1016/s0959-8049(17)30525-7

Copy DOI

Journal: European Journal of Cancer

Publication Date: Feb 1, 2017

#Advanced Non-small Cell Lung Cancer #Safety Of Nivolumab + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

1331 - Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

Full Text